Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Baijin Life Science Holdings's enterprise value is $117.90 Mil.
Baijin Life Science Holdings's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was $-4.16 Mil. Therefore, Baijin Life Science Holdings's EV-to-EBITDA for today is -28.32.
The historical rank and industry rank for Baijin Life Science Holdings's EV-to-EBITDA or its related term are showing as below:
MNNGF'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -151.53 Med: -13.58 Max: 91.86
Current: -27.49
During the past 13 years, the highest EV-to-EBITDA of Baijin Life Science Holdings was 91.86. The lowest was -151.53. And the median was -13.58.
MNNGF's EV-to-EBITDA is ranked worse than 100% of 945
companies
in the Retail - Cyclical industry
Industry Median: 9.03
vs MNNGF: -27.49
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Baijin Life Science Holdings (OTCPK:MNNGF) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Baijin Life Science Holdings's PE Ratio (TTM) for today is calculated as:
Baijin Life Science Holdings's share price for today is $0.08.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Baijin Life Science Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was $-0.007.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Luxury Goods subindustry, Baijin Life Science Holdings's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Baijin Life Science Holdings EV-to-EBITDA vs Retail - Cyclical Industry
For the Retail - Cyclical industry and Consumer Cyclical sector, Baijin Life Science Holdings's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Baijin Life Science Holdings's EV-to-EBITDA falls into.
Baijin Life Science Holdings's current Enterprise Value is $117.90 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Baijin Life Science Holdings's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was $-4.16 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Baijin Life Science Holdings (MNNGF) has a EV-to-EBITDA of -28.32 as of Aug. 09, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Baijin Life Science Holdings. According to the industry distribution chart, Baijin Life Science Holdings ranks #999999 out of 945 companies in the Retail - Cyclical industry.
Is Baijin Life Science Holdings' EV-to-EBITDA too high?
Baijin Life Science Holdings' current EV-to-EBITDA is -28.32. Based on the distribution chart, Baijin Life Science Holdings ranks #999999 out of 945 companies in the Retail - Cyclical industry, which is in the bottom quartile relative to peers. Overall, Baijin Life Science Holdings has a GF Score™ of 26/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Baijin Life Science Holdings' EV-to-EBITDA compare to TPR?
According to the Retail - Cyclical industry distribution chart, Baijin Life Science Holdings ranks #999999 out of 945 companies for EV-to-EBITDA. This places Baijin Life Science Holdings in the lower half of its industry. The industry median EV-to-EBITDA is 9.03. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Retail - Cyclical company?
The median EV-to-EBITDA among Retail - Cyclical companies is 9.03, based on 945 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Baijin Life Science Holdings. For the Retail - Cyclical industry, the median EV-to-EBITDA is 9.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Baijin Life Science Holdings's current EV-to-EBITDA is -28.32. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Baijin Life Science Holdings stock overvalued right now?
Based on GuruFocus' analysis, Baijin Life Science Holdings (MNNGF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.04, compared to a current price of $0.08 — trading 100% above its estimated fair value. The current EV-to-EBITDA is -28.32. Baijin Life Science Holdings' overall GF Score™ is 26/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Baijin Life Science Holdings (MNNGF), the current EV-to-EBITDA is -28.32 as of Aug. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Baijin Life Science Holdings (MNNGF) Overvalued in 2026?
Based on GuruFocus' analysis, Baijin Life Science Holdings stock appears to be overvalued.
The current stock price of $0.08 is trading 100% above its estimated GF Value™ of $0.04.
GuruFocus considers Baijin Life Science Holdings to be Significantly Overvalued.
Key valuation signals for MNNGF:
EV-to-EBITDA: -28.32
GF Value™: $0.04 vs. price of $0.08 (100% above fair value)
No single metric tells the full story. See the MNNGF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Baijin Life Science Holdings Ltd is positioned as a biopharmaceutical company dedicated in anti-aging and preventive medicine, as well as cellular precision therapy. The company has three business segment: jewelry business segment; strategic investment segment; and skincare business segment. The majority of revenue is coming from jewelry business segment.
26GF Score
Get the complete analysis for MNNGF
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MNNGF has been successfully added to your 
